{"id":"W4417012482","doi":"10.1182/blood-2025-2265","title":"Patients with Relapsed/Refractory multiple myeloma who achieved sustained minimal residual disease negativity in the dreamm-7 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Bortezomib; Multiple myeloma; Negativity effect; Interim analysis; Daratumumab; Dexamethasone; Minimal residual disease; Clinical endpoint","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003956371,0.0003291496,0.001412904,0.000144769,0.0002904279,0.0009012123,0.0004746834,0.0004440825,0.001688696],"category_scores_gemma":[0.001829507,0.0002028078,0.001261948,0.0002656699,0.0003959528,0.0005407319,0.0004702248,0.001223566,0.000422145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005978078,"about_ca_system_score_gemma":0.0007853935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002289795,"about_ca_topic_score_gemma":0.001052562,"domain_scores_codex":[0.9983518,0.0009772974,0.0001549743,0.0002385739,0.0001613548,0.0001160233],"domain_scores_gemma":[0.9990444,0.0002661571,0.0002811964,0.0001101597,0.00007442925,0.0002236653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7415395,0.004627509,0.0814896,0.003023932,0.005885305,0.0002520259,0.0003286539,0.001547975,0.00842274,0.001001488,0.01152894,0.1403522],"study_design_scores_gemma":[0.506301,0.2123094,0.2229802,0.0008227458,0.006187371,0.001719617,0.0003083282,0.002955433,0.005869571,0.002912486,0.03748802,0.0001457012],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794127,0.01099458,0.0005251314,0.0005485687,0.0001469695,0.001374517,0.002631384,0.00005895776,0.004307204],"genre_scores_gemma":[0.9902124,0.001496085,0.001104968,0.0008953179,0.0001426315,0.001827993,0.003258722,0.0000119107,0.001049985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003956371,"threshold_uncertainty_score":0.02092355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01250913467150316,"score_gpt":0.2707828063099649,"score_spread":0.2582736716384618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}